Glitazones are associated with reduced risk of Parkinson’s diseaseBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3949 (Published 22 July 2015) Cite this as: BMJ 2015;351:h3949
- Zosia Kmietowicz
Patients who take the antidiabetes drugs rosiglitazone or pioglitazone have a lower risk of developing Parkinson’s disease than patients taking other drugs for diabetes, a study published in PLoS Medicine indicates.1
Researchers from the London School of Hygiene and Tropical Medicine used electronic health records from the UK Clinical Practice Research Datalink to match …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial